{
    "Trade/Device Name(s)": [
        "AG-607 Blood Glucose Monitoring System",
        "AG-607 Multi Blood Glucose Monitoring System"
    ],
    "Submitter Information": "Andon Health Co., Ltd.",
    "510(k) Number": "K153561",
    "Predicate Device Reference 510(k) Number(s)": [
        "K110017"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "LFR"
    ],
    "Summary Letter Date": "January 20, 2017",
    "Summary Letter Received Date": "January 25, 2017",
    "Submission Date": "November 17, 2015",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "AG-607 blood glucose meter",
        "AG-607Multi blood glucose meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical biosensor",
        "Amperometry"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Analyzer",
        "Test Strip",
        "Lancing Device",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for AG-607 and AG-607 Multi Blood Glucose Monitoring System for quantitative glucose measurement in capillary whole blood",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary whole blood from various body sites; AG-607 for single-person self-testing at home, AG-607Multi for multiple-patient use in professional healthcare settings; not for diagnosis, screening, or neonatal use.",
    "fda_folder": "Clinical Chemistry"
}